Jan
19

SYSTEMIC SCLERODERM

Evaluating the safety and efficacy of a novel treatment strategy in systemic sclerosis

Recruiting | Phase III | Systemic Sclerosis | 18–70 years

Overview
This study evaluates the safety and efficacy of a novel treatment strategy in adult patients with systemic sclerosis.

Study population (general)
Adult patients diagnosed with systemic sclerosis.

Principal Investigator
Assoc. Prof., MD Nguyễn Văn Đĩnh

Contact
CTU – Email – Phone